CDC data shows that mortality from heart failure-related cardiac arrest has decreased significantly in the last 25 years. However, researchers noted, care teams still have considerable work to do.

A Florida family is suing Mayo Clinic for allegedly performing a heart transplant without communicating certain risks associated with the donated organ. Mayo Clinic has pushed back against those claims, saying it acted appropriately every step of the way. 

The donor-derived cell-free DNA tests from CareDx are designed to limit the use of surveillance biopsies and other more invasive treatment options. These tests have been available for adult patients for years now.

Caristo Diagnostics, an Oxford-based medtech company founded by cardiologists, has gained FDA clearance for its CaRi-Plaque technology.

TAVR is associated with a significantly lower risk of bioprosthetic valve dysfunction than SAVR, according to new data presented at CRT 2025 and simultaneously published in JACC. 

Researchers presented new two-year data from the SMART trial at CRT 2025 in Washington, D.C. Overall, self-expanding TAVR valves continue to show superior valve performance compared to balloon-expandable valves, and clinical outcomes remain comparable.

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Two separate groups have published new research comparing early AVR with clinical surveillance for the treatment of asymptomatic severe aortic stenosis. Overall, the two groups found, early treatment was associated with multiple benefits—and no added risk of harm.